Rapamycin
Tocris Bioscience | Catalog # 1292
Product Description
Rapamycin is an antifungal and immunosuppressant. Rapamycin is a specific inhibitor of mTOR (mammalian target of rapamycin); complexes with FKBP-12 and binds mTOR inhibiting its activity. Rapamycin inhibits interleukin-2-induced phosphorylation and activation of p70 S6 kinase and induces autophagy in yeast and mammalian cell lines. Rapamycin drives hPSC differentiation to mesendoderm and blood progenitor cells. Also used as a chemical dimerizer; rapamycin and GA3-AM chemically inducible dimerization systems are orthogonal. Inhibits MERS-CoV infection of Huh7 cells in a plaque reduction assay. Enhances lentiviral transduction of hematopoietic stem cells.External Portal Information
Chemicalprobes.orgis a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of Rapamycin is reviewed on the chemical probes website.
Product Specifications for Rapamycin
Molecular Weight
Formula
Storage
Purity
Chemical Name
CAS Number
PubChem ID
InChI Key
SMILES
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 18.28 | 20 |
Preparing Stock Solutions for Rapamycin
The following data is based on the product molecular weight 914.18.
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 5.47 mL | 27.35 mL | 54.69 mL |
| 1 mM | 1.09 mL | 5.47 mL | 10.94 mL |
| 2 mM | 0.55 mL | 2.73 mL | 5.47 mL |
| 10 mM | 0.11 mL | 0.55 mL | 1.09 mL |
Calculators
Background References
References are publications that support the biological activity of the product. See our Citations tab to view 382 publications citing the usage of this product.
- Wang Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells Blood 2014 PMID: 24914132
- Galluzzi Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat.Rev.Drug.Discov. 2017 PMID: 28529316
- Kindrachuk Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East Respiratory Syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob.Agents Chemother. 2015 PMID: 25487801
- Miyamoto Rapid and orthogonal logic gating with a gibberellin-induced dimerization system Nat.Chem.Biol. 2012 PMID: 22446836
- Nazareth A multi-lineage screen reveals mTORC1 inhibition enhances human pluripotent stem cell mesendoderm and blood progenitor production. Stem Cell Reports 2016 PMID: 27132889
- Kuo Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992 PMID: 1614535
- Kobayashi Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci. 2007 PMID: 17425689
- Huang Rapamycins: mechanism of action and cellular resistance. Cancer Biol.Ther. 2003 PMID: 12878853
Product Documents for Rapamycin
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Rapamycin
For research use only
Related Research Areas
Citations for Rapamycin
Customer Reviews for Rapamycin (3)
Have you used Rapamycin?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Customer Images
-
Species: HumanAssay Type: In VitroVerified Customer | Posted 10/18/2022Studies were performed with rapamycin in chemotherapy-treated cultured cancer cell lines for the evaluation of cytotoxic effects. The product is highly recommended.
-
Species: HumanAssay Type: In VitroCell Line/Tissue: MIA PaCa_2Verified Customer | Posted 06/10/2021Expected effects. IC50 equals 1nM upon 3 days of treatment of MIA PaCa_2 pancreatic cancer cell line.
-
Species: HumanVerified Customer | Posted 05/22/2019Rapamycin treatment (10nM) on human embryonic stem cells could enhance some cartilage differentiation markers such as SOX9.
There are no reviews that match your criteria.